$79.78
2.52% yesterday
Nasdaq, Apr 04, 10:00 pm CET
ISIN
US5255582018
Symbol
LMAT

LeMaitre Vascular, Inc. Stock price

$79.78
-10.69 11.82% 1M
-11.84 12.92% 6M
-12.36 13.41% YTD
+16.01 25.11% 1Y
+32.19 67.64% 3Y
+55.50 228.58% 5Y
+71.58 872.93% 10Y
Nasdaq, Closing price Fri, Apr 04 2025
-2.06 2.52%
ISIN
US5255582018
Symbol
LMAT
Sector

Key metrics

Market capitalization $1.80b
Enterprise Value $1.69b
P/E (TTM) P/E ratio 41.24
EV/FCF (TTM) EV/FCF 45.36
EV/Sales (TTM) EV/Sales 7.67
P/S ratio (TTM) P/S ratio 8.19
P/B ratio (TTM) P/B ratio 5.33
Dividend yield 0.80%
Last dividend (FY24) $0.64
Revenue growth (TTM) Revenue growth 13.63%
Revenue (TTM) Revenue $219.86m
EBIT (operating result TTM) EBIT $52.34m
Free Cash Flow (TTM) Free Cash Flow $37.16m
Cash position $299.72m
EPS (TTM) EPS $1.93
P/E forward 35.67
P/S forward 7.52
EV/Sales forward 7.05
Short interest 6.91%
Show more

Is LeMaitre Vascular, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

LeMaitre Vascular, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a LeMaitre Vascular, Inc. forecast:

5x Buy
45%
6x Hold
55%

Analyst Opinions

11 Analysts have issued a LeMaitre Vascular, Inc. forecast:

Buy
45%
Hold
55%

Financial data from LeMaitre Vascular, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
220 220
14% 14%
100%
- Direct Costs 73 73
1% 1%
33%
146 146
21% 21%
67%
- Selling and Administrative Expenses 69 69
20% 20%
31%
- Research and Development Expense 16 16
8% 8%
7%
62 62
33% 33%
28%
- Depreciation and Amortization 9.61 9.61
1% 1%
4%
EBIT (Operating Income) EBIT 52 52
41% 41%
24%
Net Profit 44 44
46% 46%
20%

In millions USD.

Don't miss a Thing! We will send you all news about LeMaitre Vascular, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

LeMaitre Vascular, Inc. Stock News

Neutral
Seeking Alpha
about 20 hours ago
Over the past decade, the iShares S&P/TSX SmallCap Index ETF has underperformed broader markets due to its heavy exposure to resource-heavy sectors like energy and materials. Acme's dividend track record spans over 15 years, with a modest but steady payout. Debt levels remain low, and management is highly focused on operational efficiency. With regulated pricing, recurring revenue, and defensiv...
Neutral
GlobeNewsWire
4 days ago
BURLINGTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8, 2025, at 3:45 PM EDT.
Neutral
Seeking Alpha
7 days ago
Alimentation Couche-Tard has several growth vectors in place with a clear 5-year plan, including organic growth and growth by acquisition. Starting in March, I will increase my Smith Manoeuvre contribution from $500 to $750 monthly. CCL Industries reported another good quarter with revenue up 9% and EPS up 5%.
More LeMaitre Vascular, Inc. News

Company Profile

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Head office United States
CEO George LeMaitre
Employees 664
Founded 1983
Website www.lemaitre.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today